OneSource Closes USFDA Inspection Successfully

  Published 1 year ago

USFDA closed the inspection after VAI classification, citing strong compliance and response to Form 483 observations.

  • CEO highlights facility’s role in DDC, biologics, and complex injectables for GLP, 1 launches.
  • The company’s five approved facilities and 1,200+ professionals support specialty pharma manufacturing.
  • Closure validates commitment to quality, advancing the commercial phase with key partners.

You might like these

NSDL Stock Jumps 65% Post IPO

Responsible AI in India's Finance: A Roadmap

Adani Power Wins 2,274 MW Bihar Project

GCCL Construction: Income Tax Search & Halt

Radico Launches Luxury Vodka Brand

GMM Pfaudler: Poland Expansion Boosts Shares

India Needs 8% Growth to Hit 2047 Goal

News that matters the most ⚡